Abstract
The indocyanine green (ICG) navigation method enables a high detection rate and a low false-negative rate (FNR) in sentinel lymph node biopsy (SLNB). Unlike the blue dye-guided method (BD method), it emits a stronger fluorescence signal in the sentinel lymph node (SLN), contributing to its high detection rate and requiring less training. Unlike the radioisotope-guided (RI) method, it does not require radioactive colloids, expensive equipment, and legal permission. The ICG injection is diluted considering “quenching reaction,” and this dilution shows that enough sensitivity for SLN detection is attainable even at lower-dose ICG. Compression of the chest wall and axilla using hemispherical transplant device enables the identification of fluorescent SLN locations prior to the skin incision. The reduced FNR observed with the ICG method is due to its high detection rate of involvement SLNs and its ability to aid examination of more than one or two SLNs at anatomical order. This paper describes the current clinical practice of the ICG fluorescence navigation method and its availability compared to conventional methods (BD or RI method).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Silverstein MJ, Skinner KA, Lomis TJ (2001) Predicting axially nodal positivity in 2282 patients with breast carcinoma. World J Surg 25:767–772. doi:10.1007/s00268001003x
Lyman GH, Giuliano AE, Somerfield MR et al (2005) American Society of Clinical Oncology. American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early–stage breast cancer. J Clin Oncol 23:7703–7720
Motomura K, Inaji H, Komoike Y et al (1999) Sentinel node biopsy guided by indocyanine green dye in breast cancer patients. Jpn J Clin Oncol 29:604–607
Kim T, Giuliano AE, Lyman GH (2006) Lymphatic mapping and sentinel lymph node biopsy in early-stage breast carcinoma, a metaanalysis. Cancer 106:4–16
Noguchi M, Motomura K, Imoto S et al (2000) A multicenter validation study of sentinel lymph node biopsy by the Japanese Breast Cancer Society. Breast Cancer Res Treat 63:31–40
McMasters KM, Tuttle TM, Carlson DJ et al (2000) Sentinel lymph node biopsy for breast cancer: a suitable alternative to routine axillary dissection in multi-institutional practice when optimal technique is used. J Clin Oncol 18:2560–2566
Pesek S, Ashikaga T, Krag LE et al (2012) The false-negative rate of sentinel node biopsy in patients with breast cancer: a metaanalysis. World J Surg 36:2239–2251
Dauphine CE, Khalkhali I, Vargas MP et al (2006) Intraoperative injection of technetium-99m: sulfur colloid is effective in the detection of sentinel lymph nodes in breast cancer. Am J Surg 194:423–426
Stratmann SL, McCarty TM, Kuhn JA (1999) Radiation safety with breast sentinel node biopsy. Am J Surg 178:454–457
Cox CE, Pendas S, Cox JM et al (1998) Guidelines for sentinel node biopsy and lymphatic mapping of patients with breast cancer. Ann Surg 227:645–651
Wishart GC, Loh SR, Jones L et al (2012) A feasibility study (ICG-10) of indocyanine green (ICG) fluorescence mapping for sentinel lymph node detection in early breast cancer. Eur J Surg Oncol 38:651–656
Kitai T, Inamoto T, Miwa M et al (2005) Fluorescence navigation with indocyanine green for detecting sentinel lymph nodes in breast cancer. Breast Cancer 12:211–215
Yamagami K, Hashimoto T, Yamamoto M (2008) The efficacy of sentinel lymph node and lymphatic tracts detection using fluorescence navigation with indocyanine green in breast cancer. Analysis of 410 patients. J Clin Oncol 26 (Suppl 1): 39s
Tagaya N, Yamazaki R, Nakagawa A et al (2008) Intraoperative identification of sentinel lymph nodes by near-infrared fluorescence imaging in patients with breast cancer. Am J Surg 195:850–853
Abe H, Mori T, Umeda T et al (2011) Indocyanine green fluorescence imaging system for sentinel lymph node biopsy in early breast cancer patients. Surg Today 41:197–202
Hirano A, Kamimura M, Ogura K et al (2012) A comparison of indocyanine green fluorescence imaging plus blue dye and blue day alone for sentinel node navigation surgery in breast cancer patients. Ann Surg Oncol 19: 4112–4116. doi 10.1245/s1043401224780
Sugie T, Sawada T, Tagaya N et al (2013) Comparison of indocyanine green fluorescence and blue dye methods in detection of sentinel lymph nodes in early-stage breast cancer. Ann Surg Oncol 20:2213–2218. doi:10.1245/s1043401328909
Hojo T, Nagao T, Kikuyama M et al (2010) Evaluation of sentinel node biopsy by combined fluorescent and dye method and lymph flow for breast cancer. Breast 19:210–213
Jung SY, Kim SK, Kim SW et al (2014) Comparison of sentinel lymph node biopsy guided by the multimodel method of indocyanine green, fluorescence radioisotope, and blue dye versus the radioisotope method in breast cancer: a randomized controlled trial. Ann Surg Oncol 21:1254–1259. doi:10.1245/s1043401334370
Gioux S, Choi HS, Frangioni JV (2010) Image-guided surgery using invisible near-infrared light: fundamentals of clinical translation. Mol Imaging 9:237–255
Mieog JS, Troyan SL, Hutteman M et al (2011) Toward optimization of imaging system and lymphatic tracer for near-infrared fluorescent sentinel lymph node mapping in breast cancer. Ann Surg Oncol 18:2483–2491
Verbeek FPR, Troyan SL, Mieog JSD et al (2013) Near-infrared fluorescence sentinel lymph node mapping in breast cancer: a multicenter experience. Breast Cancer Res Treat 143:333–342. doi:10.1007/s1054901328029
Kitai T, Kawasima M (2012) Transcutaneous detection and direct approach to the sentinel node using axillary compression technique in ICG fluorescence-navigated sentinel node biopsy for breast cancer. Breast Cancer 19:343–348
Hirche C, Murawa D, Mohr Z et al (2010) ICG fluorescence-guided sentinel node biopsy for axillary nodal staging in breast cancer. Breast Cancer Res Treat 12:373–378
Moody ED, Viskari PJ, Coly CL (1999) Non-covalent labeling of human serum albumin with indocyanine green: a study by capillary electrophoresis with diode laser-induced fluorescence detection. J Chromatogr B Biomed Sci Appl 729:55–64
Ohnishi S, Lomnes SJ, Laurence RG et al (2005) Organic alternatives to quantum dots for intraoperative near-infrared fluorescence sentinel lymph node mapping. Mol Imaging 4:172–181
MurawaD HC, Dresel S et al (2009) Sentinel lymph node biopsy in breast cancer guided by indocyanine green fluorescence. Br J Surg 96:1289–1294
Giuliano AE, Hunt KK, Ballman KV et al (2011) Axillary dissection vs no axillary dissection in woman with invasive breast cancer and sentinel node metastasis: a randomized clinical trial. JAMA 305:569–575
Boughey JC, Suman VJ, Mittendorf EA et al (2013) Sentinel lymph node surgery after neoadjuvant chemotherapy in patients with node-positive breast cancer: the ACOSOG Z1071 (Alliance) clinical trial. JAMA 310:1455–1461. doi:10.1001/jama. 2013 278932
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer Japan
About this chapter
Cite this chapter
Yamagami, K., Deai, T., Matumoto, H., Hashimoto, T. (2016). Practice of Fluorescence Navigation Surgery Using Indocyanine Green for Sentinel Lymph Node Biopsy in Breast Cancer. In: Kusano, M., Kokudo, N., Toi, M., Kaibori, M. (eds) ICG Fluorescence Imaging and Navigation Surgery. Springer, Tokyo. https://doi.org/10.1007/978-4-431-55528-5_9
Download citation
DOI: https://doi.org/10.1007/978-4-431-55528-5_9
Published:
Publisher Name: Springer, Tokyo
Print ISBN: 978-4-431-55527-8
Online ISBN: 978-4-431-55528-5
eBook Packages: MedicineMedicine (R0)